Dobutamine [dobutamin]
- Terms
-
Dobuject
dobutamin hydrochlorid
dobutamin-hydrobromid
dobutamin-laktobionát
dobutamin-tartarát (1:1), (R-(R*,R*))-izomer
dobutamin-tartarát (1:1), (S-(R*,R*))-izomer
dobutamin, (-)-izomer
dobutamin, (+)-izomer
fosfátová sůl dobutaminu (1:1), (-)-izomer
-
Dobucor
Dobuject
Dobutamin Fresenius
Dobutamin Hexal
Dobutamin Solvay
Dobutamin-ratiopharm
Dobutamina Inibsa
Dobutamina Rovi
Dobutamine (+)-Isomer
Dobutamine Hydrobromide
Dobutamine Hydrochloride
Dobutamine Lactobionate
Dobutamine Phosphate (1:1) Salt, (-)-Isomer
Dobutamine Tartrate
Dobutamine Tartrate (1:1), (R-(R*,R*))-Isomer
Dobutamine Tartrate (1:1), (S-(R*,R*))-Isomer
Dobutamine, (-)-Isomer
Dobutamine, Phosphate (1:1) Salt (+)-Isomer
Dobutrex
Lilly 81929
Oxiken
Posiject
A catecholamine derivative with specificity for BETA-1 ADRENERGIC RECEPTORS. It is commonly used as a cardiotonic agent after CARDIAC SURGERY and during DOBUTAMINE STRESS ECHOCARDIOGRAPHY.
- DUI
- D004280 MeSH Browser
- CUI
- M0006696
- CAS
- 1,2-Benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, (+-)-
- Previous indexing
- Catecholamines (1974-1975); Phenethylamines (1974-1975); Phenols (1974-1975)
- History note
- 86(76); was see under CATECHOLAMINES 1976-85
- Public note
- 86; was see under CATECHOLAMINES 1976-85
Allowable subheadings
- AD
- administration & dosage 38
- AE
- adverse effects 12
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood 2
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism 1
- PK
- pharmacokinetics 4
- PD
- pharmacology 17
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 32
- TO
- toxicity
- UR
- urine